Big shift in US marijuana policy! DOJ just moved state-regulated medical marijuana & FDA-approved products from Schedule I (like heroin) to Schedule III — recognizing lower abuse potential.
This could reshape the $47B industry without full federal legalization.
Cannabis stocks reacted fast.Trump admin delivering on medical access promises. What’s next?
#Marijuana
#CannabisPolicy $USDC